Researchers at UT Southwestern Medical Center have identified a protein that causes human cell membranes to break open in a ...

A new Dartmouth study opens new avenues for understanding—and potentially manipulating—how cells decide to live or die.

A new study shows that some widely used BPA replacements can kill cells and disrupt key functions, prompting scientists to ...

"This meant before leaving, the inmate would have to show their mouth to ensure they had swallowed methadone. However, ...

Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint ...

The San Diego County Sheriff's Office has revealed the cause and manner of death of an inmate who died while in custody at ...

NanOlogy, LLC, a private clinical-stage oncology company, is pleased to announce its drug development program aimed at transformin ...

Younger donor age (18-35) is crucial for stem cell transplant success and patient survival; superseding related sibling matches and older donor paradigms.

Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase ...

According to management, statistical assessments of the Phase 3 trial points to a very high probability of technical success for regulatory approval of ateganosine. The U.S. Food and Drug ...

Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-313 clinical trial of Jaypirca ...

Final 2025 global cohort onboarding, with applications now open for 2026WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the ...